Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (141-150 of 752) with videos related to

Pageof 76
Sort By:
Thrombosis Research|March 12, 2004
Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stentingAnsgar Weltermann, Peter Fritsch, Paul A Kyrle, et al.
Platelets|June 6, 2018
Twenty-four-hour time dependency of clopidogrel effects in patients with acute coronary syndromes: The CiCAD-StudySusanne Claudia Gruber, Matthias Karl Freynhofer, Martin Willheim, et al.
Critical Care Medicine|April 23, 2009
Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levelsRudolf Jarai, Barbara Fellner, Diana Haoula, et al.
Anticancer Research|October 4, 2011
Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivoThomas Werner Weiss, Rainer Simak, Christoph Kaun, et al.
Wiener Klinische Wochenschrift|June 10, 2016
Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarctionThomas W Weiss, Josef Aichinger, Kurt Huber, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 30, 2003
Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stentingChristoph W Kopp, Sabine Steiner, Ute Priglinger, et al.
Thrombosis Research|March 29, 2005
Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factorAndrea Bartok, Sabine Steiner, Daniela Seidinger, et al.
Thrombosis and Haemostasis|August 23, 2005
Ultrasound thrombolysisStefan Pfaffenberger, Branka Devcic-Kuhar, Stefan P Kastl, et al.
American Heart Journal|September 14, 2002
High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery diseaseWalter S Speidl, Senta Graf, Stefan Hornykewycz, et al.
Wiener Klinische Wochenschrift|December 31, 2002
[Manual compression versus mechanical compression device (FemoStop) after diagnostic coronary angiography with/without intervention]Leopold Stiebellehner, Mariam Nikfardjan, Katja Diem, et al.
Pageof 76

Showing results (141-150 of 752) with videos related to

Sort By:
Pageof 76
Thrombosis Research|March 12, 2004
Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stentingAnsgar Weltermann, Peter Fritsch, Paul A Kyrle, et al.
Platelets|June 6, 2018
Twenty-four-hour time dependency of clopidogrel effects in patients with acute coronary syndromes: The CiCAD-StudySusanne Claudia Gruber, Matthias Karl Freynhofer, Martin Willheim, et al.
Critical Care Medicine|April 23, 2009
Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levelsRudolf Jarai, Barbara Fellner, Diana Haoula, et al.
Anticancer Research|October 4, 2011
Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivoThomas Werner Weiss, Rainer Simak, Christoph Kaun, et al.
Wiener Klinische Wochenschrift|June 10, 2016
Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarctionThomas W Weiss, Josef Aichinger, Kurt Huber, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 30, 2003
Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stentingChristoph W Kopp, Sabine Steiner, Ute Priglinger, et al.
Thrombosis Research|March 29, 2005
Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factorAndrea Bartok, Sabine Steiner, Daniela Seidinger, et al.
Thrombosis and Haemostasis|August 23, 2005
Ultrasound thrombolysisStefan Pfaffenberger, Branka Devcic-Kuhar, Stefan P Kastl, et al.
American Heart Journal|September 14, 2002
High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery diseaseWalter S Speidl, Senta Graf, Stefan Hornykewycz, et al.
Wiener Klinische Wochenschrift|December 31, 2002
[Manual compression versus mechanical compression device (FemoStop) after diagnostic coronary angiography with/without intervention]Leopold Stiebellehner, Mariam Nikfardjan, Katja Diem, et al.
Pageof 76